VacciNEWS – Page 5 – Global Health Press

GHP News

Shingles risk in younger adults with chronic conditions rivals that of healthy adults in their 50s

Summary This GSK-sponsored retrospective cohort study used US Merative MarketScan claims data (2015–2022) covering over 20.6 million adults to compare herpes zoster (HZ) incidence rates in immunocompetent adults aged...

21 July, 2026

2 min read

GHP News

Subacute sclerosing panencephalitis: The devastating long-term risk of measles infection in young children

Summary Subacute sclerosing panencephalitis (SSPE) is a fatal, progressive neurodegenerative disease of the central nervous system caused by persistent, mutated measles virus that remains dormant in brain tissue for...

21 July, 2026

3 min read

GHP News Latest Science

Needle-free pan-sarbecovirus vaccine clears phase 1 safety milestone, but broad protection remains unproven

Summary This open-label, first-in-human phase 1 dose-escalation trial evaluated the DNA vaccine pEVAC-PS, a computationally designed pan-sarbecovirus candidate delivered intradermally by needle-free PharmaJet Tropis in...

21 July, 2026

2 min read

GHP News

National Academy of Medicine (NAM) – is big tech partnership a bridge to reliable health information, or a reputational risk?

Summary In a NEJM Perspective, Victor Dzau and Laura DeStefano of the National Academy of Medicine (NAM) describe two public–private collaborations aimed at improving reliable health information on major digital...

21 July, 2026

2 min read

GHP News Latest Science

Vaccines return $16 for every $1 invested, but the era of dramatic cost savings may be fading

Summary This global economic modeling study evaluated 50 years (1974–2024) of the WHO Expanded Programme on Immunization (EPI) across 194 WHO member states and 14 pathogens, using a societal-perspective cost model and...

21 July, 2026

2 min read

GHP News Latest Science

Dual influenza subtype positivity is linked to more severe pneumonia, but is it true co-infection or a dataset artifact?

Summary This retrospective single-center study (Guangyuan, China, September 2024–March 2025) linked clinical and BALF targeted-NGS pathogen data in 97 adults hospitalized with influenza-associated CAP. There were 51...

21 July, 2026

2 min read

GHP News Latest Science

Old epilepsy drug repurposed as a low-cost metabolic vaccine booster increases T-cell responses 10-fold in a human trial

Summary A multiomic screen matched T-cell memory transcriptional signatures against >30,000 drug perturbation profiles, identifying lysine deacetylase inhibitors (KDACi) as candidate immunometabolic adjuvants. Low...

21 July, 2026

2 min read

GHP News Latest Science

ViVa news week 29 (July 20, 2026)

New Zealand — HPV schedule change takes effect From 27 July 2026, New Zealand’s school-based HPV program will shift to a single dose of Gardasil 9 with parental consent; dose 2 will still be free but will be...

20 July, 2026

6 min read

All Articles